Skip to main content
. 2023 Oct 30;24(21):15738. doi: 10.3390/ijms242115738
AD Alzheimer’s disease
BBB Blood–brain barrier
CI Confidence interval
CNS Central nervous system
COVID-19 Coronavirus disease 2019
CSF Cerebrospinal fluid
FiO2 Fractional inspired oxygen
GFAP Glial fibrillary acidic protein
ICU Intensive care unit
IQR Interquartile range
NfL Neurofilament light chain
NOS Newcastle–Ottawa scale
PaO2 Partial pressure of oxygen
PRISMA Preferred reporting items for systematic reviews and meta-analysis
RE Random effect
SARS-CoV-2 Severe acute respiratory syndrome coronavirus-2
SD Standard deviation
SMD Standardized mean differences
UK United Kingdom
USA United States of America